By Emily Michiko Morris and Joshua Kresh
Executive summary: Many critics of pharmaceutical companies argue that they abuse the patent system through “evergreening” or “thickets” to increase the amount of time they can avoid generic competition and keep drug prices high. Read more
By Colin Kreutzer
By David Ward
As we highlighted in previous posts in this series (see
By
Last month, global health initiative